Alan Harvey

Alan Harvey


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Drug Discovery Today
Verified
Journal Article
Closed access
AHAlan Harvey
Alan Harvey

1 October 2007 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
AHAlan Harvey
Alan Harvey

1 December 2004 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AHAlan Harvey
Alan Harvey
BRB. Robertson
B. Robertson
Dendrotoxins are small proteins isolated from mamba (Dendroaspis) snakes. The original dendrotoxin was found in venom of the Eastern green mamba, Dendroaspis angusticeps, and related proteins were subsequently found in other mamba venoms. The dendrotoxins contain 57-60 amino acid residues crosslinked by three disulphide bridges, and they are homologous to Kunitz-type serine protease inhibitors, such as aprotinin (BPTI). The dendrotoxins have little or no anti-protease activity, but they block particular subtypes of voltage-dependent potassium channels of the Kv1 subfamily in neurones. ?-Dendrotoxin from green mamba Dendroaspis angusticeps and toxin I from the black mamba Dendroaspis polylepis block cloned Kv1.1, Kv1.2 and Kv1.6 channels in the low nanomolar range; toxin K, also from the black mamba Dendroaspis polylepis, preferentially blocks Kv1.1 channels and is active at picomolar concentrations. Structural modifications and mutations to dendrotoxins have helped to define the molecular recognition properties of different types of K+ channels, although more work is needed to characterise the chemical features of the toxins that underlie their selectivity and potency at particular subtypes of channels. Dendrotoxins have been useful markers of subtypes of K+ channels in vivo, and dendrotoxins have become widely used as probes for studying the function of K+ channels in physiology and pathophysiology. With some pathological conditions being associated with voltage-gated K+ channels, analogues of dendrotoxins might have therapeutic potential.

1 October 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AHAlan Harvey
Alan Harvey
LYLouise C. Young
Louise C. Young
AVAlvaro Viljoen
Alvaro Viljoen
NGNigel P. Gericke
Nigel P. Gericke

30 April 2010 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
AHAlan Harvey
Alan Harvey
RCRachel L Clark
Rachel L Clark
SMSimon P Mackay
Simon P Mackay
BJBlair F Johnston
Blair F Johnston
Importance to the field: Natural products are the most consistently successful source of drug leads, both historically and currently. Despite this, the use of natural products in industrial drug discovery has fallen out of favour. Natural products are likely to continue to be sources of new commercially viable drug leads because the chemical novelty associated with natural products is higher than that of any other source: this is particularly important when searching for lead molecules against newly discovered targets for which there are no known small molecule leads.Areas to be covered: Current drug discovery strategies involving natural products are described in three sections: developments from traditionally used medicines, random testing of natural compounds on biological assays and use of virtual screening techniques with structures of natural products.What the reader will gain: The reader will gain an insight into the potential for natural products in current drug discovery paradigms, particularly i...

15 July 2010 in Planta Medica
Verified
Journal Article
Closed access
AHAlan Harvey
Alan Harvey
ICIan A. Cree
Ian A. Cree
Natural products have been the biggest single source of anticancer drugs and there are continued efforts to explore the chemical diversity provided by nature in order to find new lead compounds. Bioassay test methods have developed into high throughput screening assays using both cell-based and molecular approaches. The various ways to detect effects on cell viability and cell proliferation are summarised and examples are given of developments using three-dimensional cultures and cancer stem cells. Cell-based reporter assays have also been created in order to look more directly for effects on specific physiological pathways. The molecular assays include those directed at microtubules and related proteins and at many different protein kinases.